Cell-associated plasminogen activation: regulation and physiological functions.
about
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemiaExtracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorComplexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptorDirect binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activityLatent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding proteinActivin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesisAn application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validationα-Cleavage of cellular prion proteinMatrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellumCharacterization of plasminogen system on rat yolk sac carcinoma (L2) cellsBinding of human plasminogen to BifidobacteriumA CUB-serine protease in the olfactory organ of the spiny lobster Panulirus argus.Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).Detection of vitronectin mRNA in tissues and cells of the mousePlasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Actions of heparin that may affect the malignant process.Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systemsExpression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues.Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patientsControl of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.Expression of proteinases and inhibitors in human breast cancer progression and survival.Oscillatory pericellular proteolysis and oxidant deposition during neutrophil locomotionAdenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsSpatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations.SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies.The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritisThrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning.Comparative genomics of the bacterial genus Streptococcus illuminates evolutionary implications of species groupsThe role of plasminogen activators in the regulation of connective tissue metalloproteinases.The plasminogen-plasmin system in malignancy.Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles.
P2860
Q24236433-094E84FB-2D86-4BFF-96F8-FA1723467E74Q24555664-9138D64F-14D8-43D7-81E8-7B40161EAC62Q24564351-53459B9F-39DF-4B2F-B438-972C9963106BQ24633333-9B841011-A443-4A4E-934F-5B1435C64B82Q24673676-BC35AA47-10A5-4FA3-9DE6-93558E4B83DBQ24677057-035F5447-E4CC-484B-A3F5-19C5708E1496Q24804221-1F03BC39-039B-4C5B-914C-F6938B41A421Q26863324-80B7F3DF-D396-4620-973B-639F9C6E2C2CQ28566020-6268B47F-B847-4156-B61C-A2C79496DC8BQ28573991-646D659D-E8A6-4350-9978-1759ADEABDF1Q28910391-F4853D94-25EB-456E-8EF4-F9CB06F2BA54Q30779250-74C7825B-D6AF-4744-A8AC-E13B52AD7F61Q33204826-28A70FC2-8ABE-4D6E-8C43-6818741BF2FCQ33267878-1586B5D4-14E1-42A3-8DDB-BFD35AE3F93EQ33287995-C74C4DB3-1851-484B-BF6D-F32E7490EDFEQ33306319-6A0142EF-988F-412A-9FCC-3368E9F53499Q33534337-1136CBEE-B57B-47FB-B9F3-281A1469C463Q33680725-F6CF8821-2985-45C8-B27D-CA7ABC3BC2F4Q33697706-5202F4D3-3BBE-4F45-9630-58A668C42B3CQ33854485-2A141ACE-88B2-4DBF-A13D-FDB4282D36B8Q33858614-5C794016-3CBB-4D9F-954E-48AC76A7F66FQ33886514-6D782F77-7794-454B-9110-BFA49D2DA8E8Q33890990-B3439BE7-C642-4477-A8FF-0FA1721FC03AQ33919059-31701D28-B9CD-496E-8C7F-EB8A57EAFBEAQ34167015-12B9E264-F417-44AB-B4C9-8DB9D04201B1Q34203283-FC8CDC24-9C80-47B5-8D76-FCD5B82D4F7BQ34217461-C841F9CB-FD63-486E-84F9-1621CB854F2CQ34331818-6776360C-C8BE-441B-ADFD-DC269919B037Q34510846-B4A1F6E0-8A93-49E7-BFE5-730647DFC69BQ34748888-8BF90854-2A40-48CD-9B97-1C478A3CB67DQ34978893-A5C035B4-3B79-4F51-B989-8BF84F077C33Q35083758-DDA7FF20-E7D0-4E45-992F-ECBAD96A5B0AQ35088199-CD9DEB03-A31C-40E2-A507-11E64181301DQ35160927-BBBBBD47-B7A9-46F2-8998-67CFDB1A7217Q35197598-158E96D3-A96E-4908-8CA3-730ACDBDE3D6Q35240608-2D41F6B3-ADF7-46C2-92A3-95103AA5B672Q35477781-39430FE5-3C2B-4A79-ABB2-70F2F6AD6EA8Q35613941-00BC8BE0-5182-44D6-997E-347602D98FF4Q35617966-368BABCF-D36D-4F05-ACFC-90A352100620Q35765344-FE57DD17-E2DC-4D69-9631-197BBFE3FB13
P2860
Cell-associated plasminogen activation: regulation and physiological functions.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Cell-associated plasminogen activation: regulation and physiological functions.
@en
Cell-associated plasminogen activation: regulation and physiological functions.
@nl
type
label
Cell-associated plasminogen activation: regulation and physiological functions.
@en
Cell-associated plasminogen activation: regulation and physiological functions.
@nl
prefLabel
Cell-associated plasminogen activation: regulation and physiological functions.
@en
Cell-associated plasminogen activation: regulation and physiological functions.
@nl
P1476
Cell-associated plasminogen activation: regulation and physiological functions.
@en
P2093
P304
P356
10.1146/ANNUREV.CB.04.110188.000521
P577
1988-01-01T00:00:00Z